Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 31, Issue 3, Pages 202-222
Publisher
Informa UK Limited
Online
2012-05-16
DOI
10.3109/08830185.2012.665108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
- (2011) S.-M. Lee et al. DIABETOLOGIA
- Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy
- (2011) Brenda L. Soto et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal
- (2011) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells
- (2011) Eduardo C. Filippi-Chiela et al. PLoS One
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity
- (2010) Urban Švajger et al. CELLULAR SIGNALLING
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
- (2010) Charles la Porte et al. CLINICAL PHARMACOKINETICS
- Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
- (2010) Suthakar Ganapathy et al. PLoS One
- Immunogenic cell death modalities and their impact on cancer treatment
- (2009) Oliver Kepp et al. APOPTOSIS
- Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells
- (2009) Keng-Fu Hsu et al. Autophagy
- Life and death partners: apoptosis, autophagy and the cross-talk between them
- (2009) A Eisenberg-Lerner et al. CELL DEATH AND DIFFERENTIATION
- Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation
- (2009) Urban Švajger et al. IMMUNOLOGY
- Resveratrol Alters Proliferative Responses and Apoptosis in Human Activated B Lymphocytes in Vitro
- (2009) Susan J. Zunino et al. JOURNAL OF NUTRITION
- Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
- (2009) Luis Almeida et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The aryl hydrocarbon receptor in immunity
- (2009) Charlotte Esser et al. TRENDS IN IMMUNOLOGY
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span
- (2008) Kevin J. Pearson et al. Cell Metabolism
- Eicosanoids in Asthma, Allergic Inflammation, and Host Defense
- (2008) Joshua Boyce CURRENT MOLECULAR MEDICINE
- Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells
- (2008) Yoolhee Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
- (2008) Marc Veldhoen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Resveratrol directly targets COX-2 to inhibit carcinogenesis
- (2008) Tatyana A. Zykova et al. MOLECULAR CARCINOGENESIS
- Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
- (2008) Francisco J. Quintana et al. NATURE
- Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology
- (2008) Hedi Harizi et al. TRENDS IN MOLECULAR MEDICINE
- TH-17 cells in rheumatoid arthritis
- (2008) Shiva Shahrara et al. ARTHRITIS RESEARCH & THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started